• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[异常修饰后高密度脂蛋白生物学功能的变化]

[Changes in biological functions of high-density lipoprotein after abnormal modification].

作者信息

Qu Hang, Yu Yang, Qin Shu-Cun, Song Guo-Hua

机构信息

Key Laboratory of Atherosclerosis in Universities of Shandong and Institute of Atherosclerosis, Taishan Medical University, Taian 271000, China.

College of Basic Medicine, Taishan Medical University, Taian 271000, China.

出版信息

Sheng Li Xue Bao. 2017 Apr 25;69(2):225-234.

PMID:28435982
Abstract

High-density lipoprotein (HDL) is composed of apolipoproteins, lipids and functional proteins. HDL protects against atherosclerosis (AS) by reverse cholesterol transport (RCT). HDL inhibits the lipid oxidation, inflammation and restores endothelial function. During systemic inflammation or metabolic disorders, HDL can be modified abnormally and converted to a dysfunctional type, which results in the loss of anti-inflammatory factors including apolipoprotein A-I (apoA-I), paraoxonase (PON) and platelet activating factor acetylhydrolase (PAF-AH), and gains of pro-inflammatory factors such as serum amyloid A (SAA), triglyceride (TG) and oxidative lipid. Therefore, understanding the changes in compositions and biological functions of dysfunctional HDL might help to comprehend its pathogenic mechanism.

摘要

高密度脂蛋白(HDL)由载脂蛋白、脂质和功能蛋白组成。HDL通过逆向胆固醇转运(RCT)预防动脉粥样硬化(AS)。HDL抑制脂质氧化、炎症并恢复内皮功能。在全身炎症或代谢紊乱期间,HDL可发生异常修饰并转化为功能失调型,这导致包括载脂蛋白A-I(apoA-I)、对氧磷酶(PON)和血小板活化因子乙酰水解酶(PAF-AH)在内的抗炎因子丧失,以及血清淀粉样蛋白A(SAA)、甘油三酯(TG)和氧化脂质等促炎因子增加。因此,了解功能失调HDL的组成和生物学功能变化可能有助于理解其致病机制。

相似文献

1
[Changes in biological functions of high-density lipoprotein after abnormal modification].[异常修饰后高密度脂蛋白生物学功能的变化]
Sheng Li Xue Bao. 2017 Apr 25;69(2):225-234.
2
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.慢性肾脏病中高密度脂蛋白抗氧化活性受损。
Transl Res. 2009 Feb;153(2):77-85. doi: 10.1016/j.trsl.2008.11.007. Epub 2008 Dec 10.
3
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.抗炎性高密度脂蛋白在急性期反应期间会转变为促炎性。在主动脉壁细胞共培养中,高密度脂蛋白对低密度脂蛋白氧化的保护作用丧失。
J Clin Invest. 1995 Dec;96(6):2758-67. doi: 10.1172/JCI118345.
4
The effect of poloxamer 407 on the functional properties of HDL in mice.聚氧丙烯-40 七嵌段共聚物对小鼠高密度脂蛋白功能特性的影响。
J Pharm Pharmacol. 2012 May;64(5):677-87. doi: 10.1111/j.2042-7158.2011.01444.x. Epub 2012 Feb 7.
5
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.高α脂蛋白血症中高密度脂蛋白颗粒亚类的抗氧化活性受损:酶学和物理化学性质的相关性。
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):526-33. doi: 10.1161/01.ATV.0000118276.87061.00. Epub 2004 Jan 22.
6
Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.静脉注射载脂蛋白A-I/磷脂酰胆碱圆盘对人血浆和组织液中对氧磷酶和血小板活化因子乙酰水解酶的影响。
Atherosclerosis. 2004 Sep;176(1):57-62. doi: 10.1016/j.atherosclerosis.2004.03.026.
7
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.人载脂蛋白A-I在C57BL/6和C57BL/6载脂蛋白E缺陷小鼠中过表达对两种脂蛋白相关酶(血小板活化因子乙酰水解酶和对氧磷酶)的影响。腺病毒介导的人载脂蛋白A-I基因转移与人类载脂蛋白A-I转基因的比较。
Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):E68-75. doi: 10.1161/01.atv.20.10.e68.
8
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.缺乏载脂蛋白A-I的小鼠动脉粥样硬化增加,这归因于逆向胆固醇转运受损和炎症增加。
Circ Res. 2005 Oct 14;97(8):763-71. doi: 10.1161/01.RES.0000185320.82962.F7. Epub 2005 Sep 8.
9
Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.甲状腺替代疗法可诱导亚临床甲状腺功能减退患者产生高密度脂蛋白相关的血小板活化因子乙酰水解酶:一种潜在的抗动脉粥样硬化作用。
Thyroid. 2005 May;15(5):455-60. doi: 10.1089/thy.2005.15.455.
10
Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.脂蛋白谱、脂蛋白相关磷脂酶 A2 与血液透析患者的心血管风险。
J Nephrol. 2015 Dec;28(6):749-55. doi: 10.1007/s40620-015-0194-0. Epub 2015 May 14.